Phase II study of oral S-1 plus oral leucovorin in patients with previously treated non-small-cell lung cancer

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2010
INTERVENTION: Oral S‐1 with leucovorin CONDITION: Pre‐treated non‐small cell lung cancer PRIMARY OUTCOME: response rate SECONDARY OUTCOME: Safety, overall survival, progression free survival, and 1‐year survival INCLUSION CRITERIA: patients with measurable disease and good performance status
Epistemonikos ID: 9b5921297f21b17c5b449a98f336e58b237b6198
First added on: Aug 22, 2024